Monday, March 18, 2024
HomeCancerProstate Cancer Markers In Blood

Prostate Cancer Markers In Blood

What If My Psa Is High

Prostate Cancer Radiation Fiducial Marker and SpaceOAR Gel Procedure ABS Virtual Reality (360 VR)

PSA screening is just the first step, alerting you and your doctor that more testing may be needed. If PSA is only slightly elevated, your doctor may recommend repeating the test a couple of weeks later. From there, other types of tests can help with the decision on whether you need a biopsy, including:

  • Digital rectal exam , if not already done
  • PSA velocity, or the rate of rise over time
  • PSA density, or the PSA per volume of prostate
  • PSA-based markers
  • Other markers, a urinary PCA3 or SelectMDx test
  • Magnetic resonance imaging of the prostate

Each time you see your doctor for a checkup, have a conversation about prostate health and prostate cancer screening. PCF recommends that you make a about PSA screening with your doctor, starting at age 45, or age 40 if you have a family history of prostate or other cancers or are Black.

Early Detection Saves Lives

Prostate cancer is the most common cancer affecting Australian men .

Prostate cancer is the growth of abnormal cells in the prostate gland. This gland is only found in males and is about the size of a walnut.

The causes of prostate cancer are not understood and there is currently no clear prevention strategy.

Mass Spectrometry Analysis Of Plasma

Targeted analysis of plasma samples was performed on a Acquity UPLC-I Class system coupled to a Xevo TQS mass spectrometer using the AbsoluteIDQ p180 kit according to the manufacturers instructions. The kit provides quantification of up to 188 metabolites including acylcarnitines, amino acids, hexoses, phospholipids, sphingolipids and biogenic amines. Amino acids and biogenic amines are detected and quantified by stable isotopes in LC-MS/MS mode, while the remaining metabolites are detected and semi-quantified in flow injection analysis mode. Flow in the LC method was optimised to 0.8mlmin1. Metabolites detected in LC-MS/MS mode were integrated in TargetLynx . Results from TargetLynx were together with results from the FIA analysis quantified and validated using the MetIDQ software .

Recommended Reading: New Vitality Super Beta Prostate

If Screening Test Results Arent Normal

If you are screened for prostate cancer and your initial blood PSA level is higher than normal, it doesnt always mean that you have prostate cancer. Many men with higher than normal PSA levels do not have cancer. Still, further testing will be needed to help find out what is going on. Your doctor may advise one of these options:

  • Waiting a while and having a second PSA test
  • Getting another type of test to get a better idea of if you might have cancer
  • Getting a prostate biopsy to find out if you have cancer

Its important to discuss your options, including their possible pros and cons, with your doctor to help you choose one you are comfortable with. Factors that might affect which option is best for you include:

  • Your age and overall health
  • The likelihood that you have prostate cancer
  • Your own comfort level with waiting or getting further tests

If your initial PSA test was ordered by your primary care provider, you may be referred to a urologist for this discussion or for further testing.

Prostate Cancer Screening Ages 55 To 69

Frontiers

This is the age range where men will benefit the most from screening.Thats because this is the time when:

  • Men are most likely to get cancer
  • Treatment makes the most sense, meaning when treatment benefits outweigh any potential risk of treatment side effects

Most men will get prostate cancer if they live long enough. Some prostatecancers are more aggressive others can be slow-growing. Doctors will takeyour age and other factors into consideration before weighing the risks andbenefits of treatment.

You should ask your doctor how often he or she recommends you get screened.For most men, every two to three years is enough.

Depending on the results of your first PSA test, your doctor may recommendyou get screened less frequently.

You May Like: Remedios Caseros Para La Prostata

What Is The Psa Test

Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in the blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter of blood.

The blood level of PSA is often elevated in people with prostate cancer, and the PSA test was originally approved by the FDA in 1986 to monitor the progression of prostate cancer in men who had already been diagnosed with the disease. In 1994, FDA approved the PSA test to be used in conjunction with a digital rectal exam to aid in the detection of prostate cancer in men 50 years and older. Until about 2008, many doctors and professional organizations had encouraged yearly PSA screening for prostate cancer beginning at age 50.

PSA testing is also often used by health care providers for individuals who report prostate symptoms to help determine the nature of the problem.

In addition to prostate cancer, several benign conditions can cause a persons PSA level to rise, particularly prostatitis and benign prostatic hyperplasia . There is no evidence that either condition leads to prostate cancer, but someone can have one or both of these conditions and develop prostate cancer as well.

Getting A Prostate Biopsy

For some men, getting a prostate biopsy might be the best option, especially if the initial PSA level is high. A biopsy is a procedure in which small samples of the prostate are removed and then looked at under a microscope. This test is the only way to know for sure if a man has prostate cancer. If prostate cancer is found on a biopsy, this test can also help tell how likely it is that the cancer will grow and spread quickly.

For more details on the prostate biopsy and how it is done, see Tests to Diagnose and Stage Prostate Cancer.

For more information about the possible results of a prostate biopsy, see the Prostate Pathology section of our website.

Also Check: What Does Metastatic Prostate Cancer Mean

Biopsy During Surgery To Treat Prostate Cancer

If there is more than a very small chance that the cancer might have spread , the surgeon may remove lymph nodes in the pelvis during the same operation as the removal of the prostate, which is known as a radical prostatectomy .

The lymph nodes and the prostate are then sent to the lab to be looked at. The lab results are usually available several days after surgery.

Magnetic Resonance Spectroscopy Analysis Of Serum Samples

In My Opinion: Biomarkers for the Diagnosis of Prostate Cancer

Thawed serum samples were mixed with buffer and analysed in 3-mm NMR tubes. Magnetic resonance spectroscopy analysis was performed on a Bruker Avance III Ultrashielded Plus 600MHz spectrometer equipped with a 5mm QCI Cryoprobe. Experiments were fully automated using a SampleJet in combination with Icon-NMR on Topspin 3.1 . 1D 1H Nuclear Overhauser effect spectroscopy and CarrPurcellMeiboomGill spectra with water presaturation were acquired at 311.4K. The spectra were Fourier transformed to 128K after 0.3Hz exponential line broadening. Additional 2D NMR spectra , total correlation spectroscopy and heteronuclear single-quantum coherence spectroscopy ) were acquired for selected samples for metabolite identification.

Read Also: How Do You Know Prostate Cancer Has Spread

Why Are Prostate Cancer Markers Important

Prostate cancer markers are greatly impacting the world of prostate cancer from early detection through diagnosis, by helping men to better understand their risk of having the disease and identifying the aggressiveness of the disease if present. These tests can also help doctors to learn more about your cancer and help to plan treatment.

Use In Men Already Diagnosed With Prostate Cancer

The PSA test can also be useful if you have already been diagnosed with prostate cancer.

  • In men just diagnosed with prostate cancer, the PSA level can be used together with physical exam results and tumor grade to help decide if other tests are needed.
  • The PSA level is used to help determine the stage of your cancer. This can affect your treatment options, since some treatments are not likely to be helpful if the cancer has spread to other parts of the body.
  • PSA tests are often an important part of determining how well treatment is working, as well as in watching for a possible recurrence of the cancer after treatment .

You May Like: Prostate Medication Over The Counter

How Is Prostate Cancer Detected

There is no single test to detect prostate cancer. The two most common tests are the prostate specific antigen blood test and the digital rectal examination .

The PSA test measures the level of PSA in your blood. It does not specifically test for cancer. Virtually all PSA is produced by the prostate gland. The normal range depends on your age. A PSA above the typical range may indicate the possibility of prostate cancer. However, two-thirds of cases of elevated PSA are due to noncancerous conditions such as prostatitis and BPH.

A DRE is generally conducted by a urologist to feel the prostate. While DRE is no longer recommended as a routine test for men who do not have symptoms of prostate cancer, it may be used to check for any changes in the prostate before doing a biopsy.

If either of these tests suggest an abnormality, other tests are necessary to confirm a diagnosis of prostate cancer, usually a magnetic resonance imaging scan and transrectal ultrasound biopsy.

Which Blood Tests Detect Cancer

Cancer Tumor Markers

Blood work that tests for cancer falls into four general categories:

  • Complete blood count : helps diagnose leukemia and lymphoma or if cancer has spread to the bone marrow.
  • Blood protein testing / Serum Protein Electrophoresis : helps detect abnormal proteins found in myeloma and monitors how well treatment is working.
  • Tumor marker tests: helps detect signs of liver, thyroid, ovarian, breast, colorectal, lung, stomach, pancreatic, and testicular cancer.
  • Circulating tumor cell tests: helps monitor breast, prostate, and colorectal cancers in case they are spreading, but the technology is still in development.
  • You May Like: Disadvantages Of Cyberknife For Prostate

    New Prostate Cancer Blood Test

    If you have an abnormal PSA score, your doctor may recommend another newertest that gives a better sense of yourprostate cancer risk. The prostate health index is one such test that is a more accurateblood test and measures your risk for having prostate cancer. Its approvedby the FDA for men who have PSA scores between 4 and 10.

    What are the benefits of the PHI test?

    • Fewer unnecessary biopsies: Some men who have elevated PSA scores are unsure about getting an invasive biopsy. This tool can be used to better determine whether your risk is high enough to warrant a biopsy.
    • More accurate: This test is better at detecting prostate cancer. It can also detect whether you have a more aggressive type of cancer. This information can guide doctors to a more targeted treatment plan for you.

    If you score low on the PHI test, your doctor may recommend monitoring youover time to see if your levels rise enough to cause concern.

    Further Tests For Prostate Cancer

    If results of the PSA test or the DRE are abnormal, a urologist will likely recommend a biopsy, where small samples of tissue are removed from the prostate and examined.

    If cancer is diagnosed, other tests may be used to check the progression of the cancer, including:

    • magnetic resonance imaging scan of the prostate – often done before a biopsy
    • bone scan – to check whether or not cancer cells have spread to the bones
    • computed tomography scan – a specialised x-ray
    • pelvic lymph node dissection – a nearby lymph node is removed and examined to check whether or not cancer cells have entered the lymphatic system .

    Don’t Miss: Pca3 Test For Prostate Cancer

    How Is The Psa Test Used In Men Who Have Been Treated For Prostate Cancer

    The PSA test is used to monitor men after surgery or radiation therapy for prostate cancer to see if their cancer has recurred . If a mans PSA level begins to rise after prostate cancer treatment, it may be the first sign of a recurrence. Such a biochemical relapse typically appears months or years before the recurrence causes symptoms.

    However, a single elevated PSA measurement in someone who has a history of prostate cancer does not always mean that the cancer has come back. Someone who has been treated for prostate cancer should discuss an elevated PSA level with their doctor. The doctor may recommend repeating the PSA test or performing other tests to check for evidence of a recurrence. The doctor may look for a trend of rising PSA level over time rather than a single elevated PSA level.

    A rising trend in PSA level over time in combination with other findings, such as an abnormal result on imaging tests, may lead the doctor to recommend further cancer treatment.

    Circulating Tumour Cells And Cell

    Tumor Markers in Cancer diagnosis and Monitoring

    Prostate cancer metastasis is initiated by CTCs originating from the primary tumour transported through the blood or lymphatic system . Some CTCs die in the circulation, others proliferate and form metastasis in distant organs . Experimental models indicate that millions of tumour cells continuously circulate through the body, although only few of them can survive by evading the immune response and systemic therapies, reach a distant organ, proliferate and ultimately form metastases .

    Not just CTC numbers can serve as prognostic markers but also the repertoire of their cell surface molecules which could also indicate the efficacy of various therapies such as radiotherapy or immune therapy. The EpCAM glycoprotein was initially described as one of the most commonly used protein CTC markers, however its level was shown to be downregulated during the dissemination of cancer cells from primary tumour . Therefore, using CTCs as biomarkers of therapy response based purely on their immune phenotypical changes might be misleading because of their dynamic evolution during cancer progression .

    Gene expression analysis of CTCs of prostate cancer patients have revealed altered expression levels of eight metastasis-related metabolic genes, such as phosphoglycerate kinase 1 and glucose-6-phosphate dehydrogenase responsible for optimal glucose metabolism in CTCs. Their increased expression level in CTCs was associated with advanced tumour stage and metastasis proneness .

    Read Also: Consumer Reports Best Prostate Supplement

    How Are Researchers Trying To Improve The Psa Test

    Scientists are investigating ways to improve the PSA test to give doctors the ability to better distinguish cancerous from benign conditions and slow-growing cancers from fast-growing, potentially lethal cancers. And other potential biomarkers of prostate cancer are being investigated. None of these tests has been proven to decrease the risk of death from prostate cancer. Some of the methods being studied include

    Selected References
  • Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. New England Journal of Medicine 2004 350:22392246.

  • What Is Done If A Screening Test Shows An Elevated Psa Level

    If someone who has no symptoms of prostate cancer chooses to undergo prostate cancer screening and is found to have an elevated PSA level, the doctor may recommend another PSA test to confirm the original finding. If the PSA level is still high, the doctor may recommend that the person continue with PSA tests and digital rectal exams at regular intervals to watch for any changes over time .

    If the PSA level continues to rise or a suspicious lump is detected during a DRE, the doctor may recommend additional tests to determine the nature of the problem. These may include imaging tests, such as magnetic resonance imaging or high-resolution micro-ultrasound.

    Alternatively, the doctor may recommend a prostate biopsy. During this procedure, multiple samples of prostate tissue are collected by inserting hollow needles into the prostate and then withdrawing them. The biopsy needle may be inserted through the wall of the rectum or through the perineum . A pathologist then examines the collected tissue under a microscope. Although both biopsy techniques are guided by ultrasound imaging so the doctor can view the prostate during the biopsy procedure, ultrasound cannot be used alone to diagnose prostate cancer. An MRI-guided biopsy may be performed for patients with suspicious areas seen on MRI.

    Recommended Reading: What Are The Chances Of Getting Prostate Cancer

    Biomarker Challenge In Prostate Cancer

    A PubMed Search on prostate cancer AND in English language yielded 3016 hits . The number of articles published on PCa biomarkers has increased steadily over the years. Despite this plethora of biomarkers reported to be promising, only one biomarker, is routinely used by urologists. Why are PCa biomarkers not living up to their promise? For one, there are remarkable analytical and regulatory barriers to the application of biomarkers in PCa care. These include but are not limited to the status of intellectual property protection, availability of standard reference materials for the assay, complexity of assay format, implementation of quality control to assure reproducibility and accuracy, sufficient market testing size to assess methods of commercialization, lack of clear guidelines for good manufacturing/laboratory practice and quality control requirements for all phases of biomarker development, cost and effort required to accumulate clinical data under appropriately designed and Institutional Review Board-approved prospective trials, and the interval required for resolution of patent issues, assay standardization, validation, testing, and regulatory approval.

    Modification of the structured phase-approach to the systematic discovery, evaluation, and validation of biomarkers

    What Is A Psa Test

    Oncology

    The PSA test is the leading method of screening for prostate cancer. PSA screening can help catch the disease at an early stage when treatment may be more effective and potentially have fewer side effects. The PSA test may be done along with a digital rectal exam , in which a physician inserts a gloved finger into the rectum to examine the prostate for irregularities.

    Recommended Reading: Prostate Cancer Spread To Skull Prognosis

    RELATED ARTICLES

    Most Popular